ID22770A - Turunan (1,3-bis(sikloheksilmetil)-1,2,3,6-tetrahidro-2,6-diokso-9h-purin-8-il) fenil tersubstitusi, pembuatan dan penggunaannya dalam perawatan pada kondisi peradangan dan penyakit kekebalan - Google Patents

Turunan (1,3-bis(sikloheksilmetil)-1,2,3,6-tetrahidro-2,6-diokso-9h-purin-8-il) fenil tersubstitusi, pembuatan dan penggunaannya dalam perawatan pada kondisi peradangan dan penyakit kekebalan

Info

Publication number
ID22770A
ID22770A IDW990879A ID990879A ID22770A ID 22770 A ID22770 A ID 22770A ID W990879 A IDW990879 A ID W990879A ID 990879 A ID990879 A ID 990879A ID 22770 A ID22770 A ID 22770A
Authority
ID
Indonesia
Prior art keywords
disease
durunan
cyclohexcylmetyl
tobal
dioxos
Prior art date
Application number
IDW990879A
Other languages
English (en)
Indonesian (id)
Inventor
Susan Mary Daluge
Douglas Alan Livingstone
Gerald Wolberg
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ID22770A publication Critical patent/ID22770A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDW990879A 1997-02-14 1998-02-12 Turunan (1,3-bis(sikloheksilmetil)-1,2,3,6-tetrahidro-2,6-diokso-9h-purin-8-il) fenil tersubstitusi, pembuatan dan penggunaannya dalam perawatan pada kondisi peradangan dan penyakit kekebalan ID22770A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9703044.9A GB9703044D0 (en) 1997-02-14 1997-02-14 Phenyl xanthine esters and amides

Publications (1)

Publication Number Publication Date
ID22770A true ID22770A (id) 1999-12-09

Family

ID=10807635

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990879A ID22770A (id) 1997-02-14 1998-02-12 Turunan (1,3-bis(sikloheksilmetil)-1,2,3,6-tetrahidro-2,6-diokso-9h-purin-8-il) fenil tersubstitusi, pembuatan dan penggunaannya dalam perawatan pada kondisi peradangan dan penyakit kekebalan

Country Status (37)

Country Link
US (3) US6355646B1 (de)
EP (1) EP0970081B1 (de)
JP (1) JP2001511792A (de)
KR (1) KR100522639B1 (de)
CN (1) CN1140527C (de)
AP (1) AP1000A (de)
AR (1) AR011441A1 (de)
AT (1) ATE304542T1 (de)
AU (1) AU754456B2 (de)
BG (1) BG103722A (de)
BR (1) BR9807682B1 (de)
CA (1) CA2280730C (de)
CO (1) CO4940444A1 (de)
CZ (1) CZ298764B6 (de)
DE (1) DE69831559T2 (de)
DK (1) DK0970081T3 (de)
EA (1) EA199900648A1 (de)
EE (1) EE9900348A (de)
ES (1) ES2249822T3 (de)
GB (1) GB9703044D0 (de)
HR (1) HRP980077A2 (de)
HU (1) HU225962B1 (de)
ID (1) ID22770A (de)
IL (1) IL131179A (de)
IS (1) IS5144A (de)
MY (1) MY118545A (de)
NO (1) NO325685B1 (de)
NZ (1) NZ336923A (de)
PE (1) PE58899A1 (de)
PL (1) PL188018B1 (de)
SK (1) SK110399A3 (de)
TR (1) TR199901942T2 (de)
TW (1) TW520371B (de)
UA (1) UA57767C2 (de)
WO (1) WO1998035966A1 (de)
YU (1) YU38399A (de)
ZA (1) ZA981175B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
US6545002B1 (en) * 1999-06-01 2003-04-08 University Of Virginia Patent Foundation Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
FR2804958B1 (fr) * 2000-02-15 2005-07-08 Hoechst Marion Roussel Inc Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
ES2262798T3 (es) * 2001-02-28 2006-12-01 Smithkline Beecham Corporation Derivados glicolicos de xantinas para tratar el sindrome del intestino irritable.
US7125993B2 (en) * 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US20080318983A1 (en) * 2001-11-09 2008-12-25 Rao Kalla A2b adenosine receptor antagonists
US20040072848A1 (en) * 2002-02-26 2004-04-15 Huber Brian E Methods of treating irritable bowel syndrome and functional dyspepsia
US20060182692A1 (en) 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
EA018427B1 (ru) * 2003-12-16 2013-07-30 Нектар Терапьютикс Химически модифицированный налоксон
AU2012227249B2 (en) * 2003-12-16 2014-10-02 Nektar Therapeutics Chemically modified small molecules
WO2005102976A1 (en) * 2004-04-21 2005-11-03 Smithkline Beecham Corporation Process for preparing nonaethylene glycol monomethyl ether
SI1789053T1 (sl) * 2004-09-01 2012-09-28 Gilead Sciences Inc Postopek celjenja rane z uporabo antagonistov A2B adenozinskih receptorjev
US20070059740A1 (en) * 2005-08-26 2007-03-15 Linden Joel M Method of targeting a2b adenosine receptor antagonist therapy
US8193200B2 (en) * 2007-01-04 2012-06-05 University Of Virginia Patent Foundation Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8510758D0 (en) 1985-04-27 1985-06-05 Wellcome Found Compounds
US4968672A (en) 1987-01-02 1990-11-06 The United States Of America As Represented By The Department Of Health And Human Services Adenosine receptor prodrugs
US5015647A (en) 1987-04-24 1991-05-14 Burroughs Wellcome Co. Method for treating viral infections
GB8826595D0 (en) 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
GB8906792D0 (en) 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
NZ240644A (en) 1990-11-21 1994-08-26 Smithkline Beecham Corp Use of xanthine derivatives to inhibit the production of tumour necrosis factor (tnf)
GB9210839D0 (en) 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
TW252044B (de) * 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
GB9415529D0 (en) * 1994-08-01 1994-09-21 Wellcome Found Phenyl xanthine derivatives
DE19535504A1 (de) 1995-09-25 1997-03-27 Bayer Ag Substituierte Xanthine
EP0812844B1 (de) * 1996-06-07 2002-10-23 Hoechst Aktiengesellschaft Verwendung von Theophyllinderivaten zur Behandlung und Propylaxe von Schockzuständen, neue Xanthinverbindungen und Verfahren zu deren Herstellung
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
US6117878A (en) 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
AU2640999A (en) 1998-02-26 1999-09-15 Zenyaku Kogyo Kabushiki Kaisha 1-azaindolizine derivatives
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
IL150368A0 (en) 1999-12-23 2002-12-01 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use
US6751206B1 (en) * 2000-06-29 2004-06-15 Qualcomm Incorporated Method and apparatus for beam switching in a wireless communication system

Also Published As

Publication number Publication date
KR20000071010A (ko) 2000-11-25
YU38399A (sh) 2002-06-19
HRP980077A2 (en) 1998-12-31
CO4940444A1 (es) 2000-07-24
DK0970081T3 (da) 2006-02-06
EP0970081B1 (de) 2005-09-14
NO993915L (no) 1999-10-13
HUP0000894A2 (hu) 2001-05-28
IL131179A0 (en) 2001-01-28
AP1000A (en) 2001-08-11
JP2001511792A (ja) 2001-08-14
US6437124B1 (en) 2002-08-20
GB9703044D0 (en) 1997-04-02
US6355646B1 (en) 2002-03-12
PE58899A1 (es) 1999-06-17
HK1022907A1 (en) 2000-08-25
AU6622198A (en) 1998-09-08
HUP0000894A3 (en) 2002-04-29
AR011441A1 (es) 2000-08-16
BR9807682A (pt) 2000-02-15
CZ298764B6 (cs) 2008-01-23
IL131179A (en) 2004-05-12
DE69831559T2 (de) 2006-06-14
ZA981175B (en) 1999-08-12
PL335135A1 (en) 2000-04-10
NO993915D0 (no) 1999-08-13
ES2249822T3 (es) 2006-04-01
NO325685B1 (no) 2008-07-07
EA199900648A1 (ru) 2000-04-24
US20030181471A1 (en) 2003-09-25
NZ336923A (en) 2001-02-23
AU754456B2 (en) 2002-11-14
KR100522639B1 (ko) 2005-10-19
IS5144A (is) 1999-07-30
CA2280730C (en) 2006-10-10
US7002012B2 (en) 2006-02-21
CA2280730A1 (en) 1998-08-20
EP0970081A1 (de) 2000-01-12
SK110399A3 (en) 2000-06-12
ATE304542T1 (de) 2005-09-15
UA57767C2 (uk) 2003-07-15
EE9900348A (et) 2000-02-15
BG103722A (en) 2000-06-30
DE69831559D1 (de) 2005-10-20
CN1140527C (zh) 2004-03-03
MY118545A (en) 2004-12-31
HU225962B1 (en) 2008-01-28
TR199901942T2 (xx) 1999-12-21
CN1252071A (zh) 2000-05-03
TW520371B (en) 2003-02-11
WO1998035966A1 (en) 1998-08-20
CZ288799A3 (cs) 2000-04-12
BR9807682B1 (pt) 2009-01-13
AP9901622A0 (en) 1999-09-30
PL188018B1 (pl) 2004-11-30

Similar Documents

Publication Publication Date Title
ID22770A (id) Turunan (1,3-bis(sikloheksilmetil)-1,2,3,6-tetrahidro-2,6-diokso-9h-purin-8-il) fenil tersubstitusi, pembuatan dan penggunaannya dalam perawatan pada kondisi peradangan dan penyakit kekebalan
CY2018020I2 (el) Θεραπεια της νοσου ρομρε
DE69712278D1 (de) Verdicktes Körperpflegemittel
ID24652A (id) Komposisi untuk penggunaan pada perawatan pribadi
ITMI951278A0 (it) Formulazioni di analoghi dell'insulina
ID25504A (id) Pencegahan dan pengobatan penyakit amiloidogenik
ID22926A (id) Komposisi untuk perawatan rambut
DE69941113D1 (de) Zytokinen und mitogenen um "graft-versus-host disease" zu verhindern
DE19882513T1 (de) Dental-Restorative Massen
IL122084A0 (en) Improved personal care formulations
ATE199314T1 (de) Kosmetische tensid zusammensetzung sowie ihre verwendung
NO981388L (no) Bedring av Dupuytrens sykdom
ATE303791T1 (de) Körperpflegemittel
EP1210933A4 (de) Wirkstoffe zur normalisierung des hautzustands
ID25489A (id) Komposisi perawatan rambut
ID19975A (id) Komposisi perawatan rambut
DE69510575D1 (de) Verwendung von silikontrennschichtmittel
ATE213149T1 (de) Reinigende kosmetische zusammensetzung und verwendung
EP0983958A4 (de) Fahrtreppenstufe und fahrtreppe
ID27215A (id) Komposisi perawatan rambut
ID22656A (id) Komposisi untuk digunakan pada rambut atau kulit
DE69500099D1 (de) N-(Hydroxyalkyl)-substituierte Alkylcarbamate und ihre Verwendung in der Kosmetik, insbesondere in Haarpflegemitteln
DE59802138D1 (de) Verwendung von wachs
ID28380A (id) Komposisi perawatan rambut
ATE188113T1 (de) Kosmetische tensid zusammensetzung sowie ihre verwendung